Molycorp Inc. (NYSE: MCP) has announced that it intends to offer and sell $300 million aggregate principal amount of convertible senior notes due in 2017 and $150 million of its common stock. The offerings would come to $345 million AND/OR up to $172.5 million, respectively, if Morgan Stanley exercises its overallotment option.
The use of proceeds is to fund operating expenses, working capital, capital expenditures and any other cash requirements for the remainder of 2012 and the first six months of 2013. In short, this offering is aimed to address the recent Standard & Poor’s downgrade. The fund usage includes capital expenditures at its Mountain Pass facility and other capital projects, and cash payments due this month to certain holders of the 5% subordinated unsecured convertible debentures of Molycorp Canada.
The company is also agreeing to lend Morgan Stanley shares up to $138 million in common stock to facilitate the note offering.
Morgan Stanley and Credit Suisse are sharing the notes offering book-runner status; Morgan Stanley will be the sole book-runner for the shares offering.
Molycorp shares are indicated down more than 9% at $10.95 against a 52-week range of $11.22 to $58.74. Before the effects of this offering, the market capitalization of Molycorp is $1.2 billion.
JON C. OGG
Sponsored: Want to Retire Early? Here’s a Great First Step
Want retirement to come a few years earlier than you’d planned? Orare you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
